{"data":[{"accessionNo":"0001950047-26-009587","issuerCik":"0001159036","issuerName":"HALOZYME THERAPEUTICS INC","ticker":"HALO","personName":"MATTHEW POSARD","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":34226,"aggregateMarketValue":3636512.5,"unitsOutstanding":113498000,"approxSaleDate":"2026-09-16","exchange":"NASDAQ","filedAt":"2026-09-16","canonicalUrl":"https://xoomar.com/markets/stocks/halo"},{"accessionNo":"0001950047-26-007986","issuerCik":"0001159036","issuerName":"HALOZYME THERAPEUTICS, INC.","ticker":"HALO","personName":"CORTNEY A CAUDILL","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":41702,"aggregateMarketValue":4302349.47,"unitsOutstanding":113498000,"approxSaleDate":"2026-08-11","exchange":"NASDAQ","filedAt":"2026-08-11","canonicalUrl":"https://xoomar.com/markets/stocks/halo"},{"accessionNo":"0001950047-26-007890","issuerCik":"0001159036","issuerName":"HALOZYME THERAPEUTICS INC","ticker":"HALO","personName":"BERNADETTE CONNAUGHTON","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":1626,"aggregateMarketValue":167673.12,"unitsOutstanding":113498000,"approxSaleDate":"2026-08-10","exchange":"NASDAQ","filedAt":"2026-08-10","canonicalUrl":"https://xoomar.com/markets/stocks/halo"},{"accessionNo":"0001950047-26-006595","issuerCik":"0001159036","issuerName":"HALOZYME THERAPEUTICS INC","ticker":"HALO","personName":"MAHESH KRISHNAN","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":7304,"aggregateMarketValue":547507.84,"unitsOutstanding":118613000,"approxSaleDate":"2026-06-29","exchange":"NASDAQ","filedAt":"2026-06-29","canonicalUrl":"https://xoomar.com/markets/stocks/halo"},{"accessionNo":"0001950047-26-004590","issuerCik":"0001159036","issuerName":"HALOZYME THERAPEUTICS, INC.","ticker":"HALO","personName":"NICOLE LABROSSE","relationship":"Former Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":14700,"aggregateMarketValue":986591.97,"unitsOutstanding":118613000,"approxSaleDate":"2026-05-15","exchange":"NASDAQ","filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/halo"},{"accessionNo":"0001950047-26-003926","issuerCik":"0001159036","issuerName":"HALOZYME THERAPEUTICS INC","ticker":"HALO","personName":"BERNADETTE CONNAUGHTON","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":4875,"aggregateMarketValue":310342.5,"unitsOutstanding":118017000,"approxSaleDate":"2026-05-01","exchange":"NASDAQ","filedAt":"2026-05-01","canonicalUrl":"https://xoomar.com/markets/stocks/halo"},{"accessionNo":"0001950047-26-002405","issuerCik":"0001159036","issuerName":"HALOZYME THERAPEUTICS, INC.","ticker":"HALO","personName":"CORTNEY A CAUDILL","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":8857,"aggregateMarketValue":599088.37,"unitsOutstanding":118017000,"approxSaleDate":"2026-03-10","exchange":"NASDAQ","filedAt":"2026-03-10","canonicalUrl":"https://xoomar.com/markets/stocks/halo"},{"accessionNo":"0001950047-26-002360","issuerCik":"0001159036","issuerName":"HALOZYME THERAPEUTICS, INC.","ticker":"HALO","personName":"CORTNEY A CAUDILL","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":20000,"aggregateMarketValue":1356062,"unitsOutstanding":118017000,"approxSaleDate":"2026-03-09","exchange":"NASDAQ","filedAt":"2026-03-09","canonicalUrl":"https://xoomar.com/markets/stocks/halo"},{"accessionNo":"0001968582-26-000077","issuerCik":"0001159036","issuerName":"Halozyme Therapeutics, Inc.","ticker":"HALO","personName":"Helen Torley","relationship":"President, CEO, Director","securityClass":"Common Stock","broker":"J.P. Morgan Securities LLC","unitsToSell":150000,"aggregateMarketValue":11167500,"unitsOutstanding":117597000,"approxSaleDate":"2026-02-03","exchange":"NASDAQ","filedAt":"2026-02-03","canonicalUrl":"https://xoomar.com/markets/stocks/halo"},{"accessionNo":"0001950047-26-000129","issuerCik":"0001159036","issuerName":"HALOZYME THERAPEUTICS, INC.","ticker":"HALO","personName":"BERNADETTE CONNAUGHTON","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":2000,"aggregateMarketValue":140620,"unitsOutstanding":117597000,"approxSaleDate":"2026-01-05","exchange":"NASDAQ","filedAt":"2026-01-05","canonicalUrl":"https://xoomar.com/markets/stocks/halo"},{"accessionNo":"0001968582-25-000972","issuerCik":"0001159036","issuerName":"Halozyme Therapeutics, Inc.","ticker":"HALO","personName":"Helen Torley","relationship":"President, CEO, Director","securityClass":"Common Stock","broker":"J.P. Morgan Securities LLC","unitsToSell":136569,"aggregateMarketValue":10015970,"unitsOutstanding":116966000,"approxSaleDate":"2025-10-01","exchange":"NASDAQ","filedAt":"2025-10-01","canonicalUrl":"https://xoomar.com/markets/stocks/halo"}],"updatedAt":"2026-10-30T12:04:06.560Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/halo","meta":{"source":"SEC","sourceAttribution":"Form 144 data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}